Elevated Opioid Use During Pregnancy in New Zealand: A Growing Concern
New Zealand ranks third among high-income countries for prescribed opioid use during pregnancy, with nearly 8% of pregnancies affected, raising concerns about potential fetal risks and the need for updated guidelines.
Recent research highlights that New Zealand ranks third among high-income countries for prescribed opioid use during pregnancy, with almost 8% of pregnancies exposed to opioids. This rate is notably higher than in several other nations, such as Canada and the UK. The study, led by the University of New South Wales and published in the journal Anesthesiology, analyzed prescription data from over 20 million pregnancies worldwide, spanning from 2000 to 2020.
The investigation utilized anonymized prescription records from countries including Australia, New Zealand, Canada, the US, and European nations, revealing that opioid use remained stable or declined slightly in most countries over the two decades. The highest consumption was observed in the United States, while the United Kingdom had the lowest rates. Among the opioids most commonly used were codeine and tramadol.
Interestingly, opioid use was more prevalent during late pregnancy and among women with lower income levels and higher body mass index. Furthermore, the study noted an overall increase in prescription medication use during pregnancy over the 20-year period, possibly linked to an aging pregnant population with more medical conditions requiring treatment.
Dr. Sarah Donald from the University of Otago emphasized that these findings raise important questions about current guidelines and practices surrounding opioid prescription during pregnancy. She and her colleagues highlighted that, although 80% of pregnant women using opioids received only a single prescription, potential risks remain significant.
Professor Lianne Parkin added that opioids can cross the placenta, exposing the fetus to risks associated with early exposure, such as congenital malformations, preterm birth, low birth weight, neonatal breathing difficulties, withdrawal symptoms, and longer-term neurodevelopmental issues. These findings underscore the importance of carefully evaluating the necessity of opioid use during pregnancy and exploring safer pain management alternatives.
This comprehensive study underscores the need for ongoing review of prescribing practices and underscores the importance of balancing effective pain relief with potential risks to both mother and child.
Source: https://medicalxpress.com/news/2025-05-high-opioid-nz-pregnancies.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Uncovering the Key Mechanism Behind High Blood Pressure
A new study uncovers the role of the enzyme JMJD3 in regulating blood vessel function and its impact on hypertension, offering potential for targeted personalized therapies.
Global Variations in the Management of Diverticulitis Highlight Need for Standardized Care
A recent international study exposes significant differences in diverticulitis treatment worldwide, urging the need for standardized care and improved guidelines to optimize patient management and reduce antibiotic overuse.
The Impact of Microplastics on Brain Health: What We Know So Far
Emerging research indicates microplastics are found in human brains, but their health effects remain uncertain. Learn about recent studies and the need for precautionary action against plastic pollution's impact on brain health.
Increased Risk of Rare Lymphoma in Breast Cancer Patients with BRCA Mutations and Textured Implants
Women with breast cancer carrying BRCA mutations who receive textured breast implants face a significantly higher risk of developing rare lymphoma, according to new research. The study underscores the importance of genetic testing and personalized healthcare in breast reconstruction decisions.